Feldmann M - Search Results

1

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Williams RO, Feldmann M, Maini RN. Williams RO, et al. Among authors: feldmann m. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9784-8. doi: 10.1073/pnas.89.20.9784. Proc Natl Acad Sci U S A. 1992. PMID: 1409699 Free PMC article.

2

How does infliximab work in rheumatoid arthritis?

Maini RN, Feldmann M. Maini RN, et al. Among authors: feldmann m. Arthritis Res. 2002;4 Suppl 2(Suppl 2):S22-8. doi: 10.1186/ar549. Epub 2002 Mar 27. Arthritis Res. 2002. PMID: 12110154 Free PMC article. Review.

3

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?

Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN. Feldmann M, et al. Novartis Found Symp. 2004;256:53-69; discussion 69-73, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027483 Review.

4

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. Feldmann M, et al. Best Pract Res Clin Rheumatol. 2004 Feb;18(1):59-80. doi: 10.1016/j.berh.2003.09.010. Best Pract Res Clin Rheumatol. 2004. PMID: 15123038 Review.

5

Anti-TNF therapy: where have we got to in 2005?

Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN. Feldmann M, et al. J Autoimmun. 2005;25 Suppl:26-8. doi: 10.1016/j.jaut.2005.09.006. Epub 2005 Nov 2. J Autoimmun. 2005. PMID: 16260118 Review.

6

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J, Woody JN. Elliot MJ, et al. Among authors: feldmann m. Arthritis Rheum. 2008 Feb;58(2 Suppl):S92-S101. doi: 10.1002/art.23362. Arthritis Rheum. 2008. PMID: 18240199 Free article.

7

Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?

Feldmann M, Maini RN. Feldmann M, et al. J Immunol. 2010 Jul 15;185(2):791-4. doi: 10.4049/jimmunol.1090051. J Immunol. 2010. PMID: 20601610 Free article.

8

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, Dean JL, Stoop AA, Williams RO. McCann FE, et al. Among authors: feldmann m. Arthritis Rheumatol. 2014 Oct;66(10):2728-38. doi: 10.1002/art.38755. Arthritis Rheumatol. 2014. PMID: 24965881

9

TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells.

Tseng WY, Huang YS, Clanchy F, McNamee K, Perocheau D, Ogbechi J, Luo SF, Feldmann M, McCann FE, Williams RO. Tseng WY, et al. Among authors: feldmann m. Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21666-21672. doi: 10.1073/pnas.1909687116. Epub 2019 Oct 9. Proc Natl Acad Sci U S A. 2019. PMID: 31597740 Free PMC article.

10

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.

Feldmann M, Maini RN. Feldmann M, et al. Joint Bone Spine. 2002 Jan;69(1):12-8. doi: 10.1016/s1297-319x(01)00335-9. Joint Bone Spine. 2002. PMID: 11858351 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters